India’s CARE Hospitals unveils liver transplant institute in Hyderabad

The institute is the group's sixth liver transplant centre in India.

CARE Hospitals has launched an institute for digestive diseases and liver transplantation in Hyderabad, India.

A report by GlobalData mentioned that the CARE Institute of Digestive Diseases and Liver Transplantation will focus on delivering comprehensive care for liver, gastrointestinal, and pancreatic diseases.

In addition, the institute will comprise a team of surgeons specialising in gastrointestinal surgeries, liver transplants and hepato-pancreato-biliary surgery (HPB).

ALSO READ: India's Manipal Hospitals acquires 87% stake in Medica Synergie

The institute was inaugurated by K Hari Prasad, chairman and non-executive director of Quality Care India, in the presence of Jasdeep Singh, Group CEO of CARE Hospitals group, among other key dignitaries.

Currently, the group operates 17 facilities across seven cities and six different states in India.

Also Read

Tech strips the scare off spine surgeries

Fakeeh Care Group announces final IPO price of $15.3 per share

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit

Top News

Fakeeh Care Group announces final IPO price of $15.3 per share

Subscription period is on 21 and 22 May.

Healthcare

1 day ago

Burjeel Medical City partners with TII for cancer treatment

The two-year collaboration will focus on engineering T-cell-based therapeutics and TIL therapy.

Healthcare

1 day ago

APAC’s prosthetic heart valve market to record 11.9% CAGR until 2035

The global market is expected to reach $30.3b within the forecast period.

Healthcare

1 day ago

Peripheral artery disease market poised for $10.8b growth by 2035

APAC expects notable CAGR growth within the forecast period.

Healthcare

1 day ago

Exclusives

MakatiMed advances towards precise surgical care with Da Vinci Xi robotic system

The tech allows for minimally invasive techniques in urology, hepatobiliary, cardiovascular, thoracic, obstetrics and gynaecology, and general surgery.

Healthcare

4 days ago

The Medical City paves the way for AI-integrated local healthcare and research with Lunit